Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Excess mortality for patients with residual disease following resection of pituitary adenomas.

Sughrue ME, Chang EF, Gabriel RA, Aghi MK, Blevins LS.

Pituitary. 2011 Sep;14(3):276-83. doi: 10.1007/s11102-011-0308-1. Review.

PMID:
21476061
[PubMed - indexed for MEDLINE]
2.

The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.

Lissett CA, Peacey SR, Laing I, Tetlow L, Davis JR, Shalet SM.

Clin Endocrinol (Oxf). 1998 Nov;49(5):653-7. Review.

PMID:
10197082
[PubMed - indexed for MEDLINE]
3.

Radiation therapy in the multimodal treatment approach of pituitary adenoma.

Becker G, Kocher M, Kortmann RD, Paulsen F, Jeremic B, Müller RP, Bamberg M.

Strahlenther Onkol. 2002 Apr;178(4):173-86. Review.

PMID:
12040754
[PubMed - indexed for MEDLINE]
4.

Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.

Yap LB, Turner HE, Adams CB, Wass JA.

Clin Endocrinol (Oxf). 2002 Jan;56(1):25-31.

PMID:
11849243
[PubMed - indexed for MEDLINE]
5.

[Treatment of pituitary adenomas].

Mezosi E, Nemes O.

Orv Hetil. 2009 Sep 27;150(39):1803-10. doi: 10.1556/OH.2009.28584. Review. Hungarian.

PMID:
19758960
[PubMed - indexed for MEDLINE]
6.

Treatment outcomes and mortality of 94 patients with acromegaly.

Trepp R, Stettler C, Zwahlen M, Seiler R, Diem P, Christ ER.

Acta Neurochir (Wien). 2005 Mar;147(3):243-51; discussion 250-1.

PMID:
15627919
[PubMed - indexed for MEDLINE]
7.

Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.

Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van Aken MO, Voormolen JH, Romijn JA.

J Clin Endocrinol Metab. 2007 Mar;92(3):976-81. Epub 2007 Jan 2.

PMID:
17200171
[PubMed - indexed for MEDLINE]
8.

The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.

Flitsch J, Knappe UJ, Lüdecke DK.

Zentralbl Neurochir. 2003;64(1):6-11.

PMID:
12582940
[PubMed - indexed for MEDLINE]
9.

Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.

Pecori Giraldi F, Andrioli M, De Marinis L, Bianchi A, Giampietro A, De Martin M, Sacco E, Scacchi M, Pontecorvi A, Cavagnini F.

Eur J Endocrinol. 2007 Feb;156(2):233-9.

PMID:
17287413
[PubMed - indexed for MEDLINE]
Free Article
10.

Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly.

Beauregard C, Truong U, Hardy J, Serri O.

Clin Endocrinol (Oxf). 2003 Jan;58(1):86-91.

PMID:
12519417
[PubMed - indexed for MEDLINE]
11.

Diagnosis and treatment of pituitary adenomas.

Chanson P, Salenave S.

Minerva Endocrinol. 2004 Dec;29(4):241-75. Review.

PMID:
15765032
[PubMed - indexed for MEDLINE]
Free Article
12.

[Pituitary adenomas--where is the treatment heading at the beginning of the 21st century?].

Marek J.

Vnitr Lek. 2010 Jul;56(7):690-4. Review. Czech.

PMID:
20842914
[PubMed - indexed for MEDLINE]
13.

Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.

Mukherjee A, Murray RD, Teasdale GM, Shalet SM.

Clin Endocrinol (Oxf). 2004 Apr;60(4):476-83.

PMID:
15049963
[PubMed - indexed for MEDLINE]
14.

High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.

Comtois R, Beauregard H, Hardy J, Robert F, Somma M.

Clin Endocrinol (Oxf). 1993 Jun;38(6):601-7.

PMID:
8392915
[PubMed - indexed for MEDLINE]
15.

Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.

Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T.

Neurosurg Focus. 2010 Oct;29(4):E7. doi: 10.3171/2010.7.FOCUS10167.

PMID:
20887132
[PubMed - indexed for MEDLINE]
16.

Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas.

Pollock BE, Brown PD, Nippoldt TB, Young WF Jr.

Neurosurgery. 2008 Jun;62(6):1271-6; discussion 1276-8. doi: 10.1227/01.neu.0000333298.49436.0e.

PMID:
18824993
[PubMed - indexed for MEDLINE]
17.

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.

Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA.

Clin Endocrinol (Oxf). 1999 May;50(5):561-7.

PMID:
10468920
[PubMed - indexed for MEDLINE]
18.

Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors.

Pimentel-Filho FR, Cukiert A, Miyashita F, Huayllas MK, Knoepfelmacher M, Salgado LR, Liberman B.

J Endocrinol Invest. 2001 Feb;24(2):83-7.

PMID:
11263476
[PubMed - indexed for MEDLINE]
19.

PPAR-gamma in Cushing's disease.

Heaney AP.

Pituitary. 2004;7(4):265-9. Review.

PMID:
16416039
[PubMed - indexed for MEDLINE]
20.

Doubled mortality rate in irradiated patients reoperated for regrowth of a macroadenoma of the pituitary gland.

Erfurth EM, Bulow B, Nordström CH, Mikoczy Z, Hagmar L, Strömberg U.

Eur J Endocrinol. 2004 Apr;150(4):497-502.

PMID:
15080779
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk